Repligen (RGEN) EPS (Basic) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Repligen (RGEN) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.04% |
| Mar 31, 2026 | -29.68% |
| Dec 31, 2025 | 36.69% |
| Sep 30, 2025 | -0.88% |
| Jun 30, 2025 | -2.68% |
| Mar 31, 2025 | -11.21% |
| Dec 31, 2024 | -348.06% |
| Sep 30, 2024 | -18.72% |
| Jun 30, 2024 | -10.15% |
| Mar 31, 2024 | -20.26% |
| Dec 31, 2023 | 3.29% |
| Sep 30, 2023 | 22.64% |
| Jun 30, 2023 | 41.51% |
| Mar 31, 2023 | 45.68% |
| Dec 31, 2022 | 22.50% |
| Sep 30, 2022 | 45.09% |
| Jun 30, 2022 | 29.44% |
| Mar 31, 2022 | 56.71% |
| Dec 31, 2021 | 28.71% |
| Sep 30, 2021 | 77.88% |